魯商發展(600223.SH)擬收購焦點生物60.11%股權 打造以透明質酸為核心的產品體系
格隆匯12月19日丨魯商發展(600223.SH)公佈,公司擬現金收購山東焦點生物科技股份有限公司(“焦點生物”或“標的公司”)60.11%股權,交易價款依據評估值確定為約2.58億元。收購完成後,公司將持有焦點生物1080.39萬股,持股比例60.11%,將成為焦點生物第一大股東。
焦點生物是一家專業生產透明質酸的企業,生產的透明質酸主要應用於化粧品行業、營養保健品行業。標的公司已通過ISO22000食品安全管理體系、ISO9001質量管理體系認證、ISO14001環境管理體系認證、OHSAS18001職業健康安全管理體系認證,Kosher猶太認證和Halal清真認證,保健品食品生產許可證,並且通過了歐盟Ecocert&Cosmos有機認證和REACH豁免。該公司銷售分為外貿出口和國內銷售兩部分,外貿出口地區主要為日本、美國、歐盟、韓國、台灣等;國內銷售主要集中在華南珠三角地區和華東長三角地區。該公司化粧級、食品級透明質酸目前產能120噸/年,60%左右出口,其全資子公司焦點生物醫藥有限公司2019年投資新建一條化粧品級透明質酸生產線(產能300噸/年),已於2019年11月建成並開始試生產。焦點生物現有全資子公司4家,境內企業三家,境外企業一家。
此次交易主要是落實上市公司戰略轉型和產業佈局,進一步加快公司健康產業的發展,完善公司健康板塊的上下游產業鏈,打造以透明質酸為核心的產品體系。
此次交易標的規模相對上市公司較小,對公司近期的營業收入、淨利潤等財務指標無重大影響。公司需要支付的交易對價為約2.58億元,公司目前生產經營狀況良好,交易對價支付對公司生產經營、債務償付無重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.